Literature DB >> 12876143

Orienting of attention and Parkinson's disease: tactile inhibition of return and response inhibition.

Ellen Poliakoff1, Donald J O'Boyle, A Peter Moore, Francis P McGlone, Frederick W J Cody, Charles Spence.   

Abstract

There is growing evidence for cognitive impairments in Parkinson's disease (PD), including in the orienting of attention and inhibition of return (IOR). IOR refers to the slowing of a response to a target stimulus presented in the same location as a previous stimulus. While some researchers have reported normal levels of visual IOR in PD patients using cue-target tasks, others have reported significant reductions in IOR in this patient group. However, the inhibitory effects observed in cue-target tasks may reflect non-ocular response inhibition associated with withholding a response from the cue stimulus, rather than attentional or oculomotor processes. Many researchers working with normal participants have circumvented this confound by using a target-target task, in which a response is made to all peripheral stimuli. Here, we compared IOR measured in cue-target and target-target tasks, using tactile rather than visual stimuli. Both the PD and the control groups exhibited significant inhibitory effects in the cue-target task, but only the control group exhibited significant IOR in the target-target task. Our results demonstrate a reduction, or elimination, of IOR in PD and this change may have been underestimated in previous studies, in which methodologically flawed cue-target tasks were used. This reduction in IOR may reflect impaired inhibitory processes or hyper-reflexive orienting in parkinsonian patients.

Entities:  

Mesh:

Year:  2003        PMID: 12876143     DOI: 10.1093/brain/awg210

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  11 in total

1.  Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease.

Authors:  K Bronnick; U Ehrt; M Emre; P P De Deyn; K Wesnes; S Tekin; D Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-26       Impact factor: 10.154

2.  Diminished EEG habituation to novel events effectively classifies Parkinson's patients.

Authors:  James F Cavanagh; Praveen Kumar; Andrea A Mueller; Sarah Pirio Richardson; Abdullah Mueen
Journal:  Clin Neurophysiol       Date:  2017-12-13       Impact factor: 3.708

3.  Impaired inhibitory oculomotor control in patients with Parkinson's disease.

Authors:  Prakash Joti; Shrikanth Kulashekhar; Madhuri Behari; Aditya Murthy
Journal:  Exp Brain Res       Date:  2006-09-19       Impact factor: 1.972

4.  Inhibition of return in cue-target and target-target tasks.

Authors:  Timothy N Welsh; Jay Pratt
Journal:  Exp Brain Res       Date:  2006-04-08       Impact factor: 1.972

5.  Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signs.

Authors:  Vanessa Franco; Robert S Turner
Journal:  Neurobiol Dis       Date:  2012-03-29       Impact factor: 5.996

6.  Dopaminergic Control of Attentional Flexibility: Inhibition of Return is Associated with the Dopamine Transporter Gene (DAT1).

Authors:  Lorenza S Colzato; Jay Pratt; Bernhard Hommel
Journal:  Front Hum Neurosci       Date:  2010-07-13       Impact factor: 3.169

7.  Space-based but not object-based inhibition of return is impaired in Parkinson's disease.

Authors:  Katherine L Possin; J Vincent Filoteo; David D Song; David P Salmon
Journal:  Neuropsychologia       Date:  2009-02-11       Impact factor: 3.139

8.  Spatially distributed encoding of covert attentional shifts in human thalamus.

Authors:  Oliver J Hulme; Louise Whiteley; Stewart Shipp
Journal:  J Neurophysiol       Date:  2010-09-15       Impact factor: 2.714

9.  Attention as foraging for information and value.

Authors:  Sanjay G Manohar; Masud Husain
Journal:  Front Hum Neurosci       Date:  2013-11-05       Impact factor: 3.169

Review 10.  Parkinson's disease dementia: a neural networks perspective.

Authors:  James Gratwicke; Marjan Jahanshahi; Thomas Foltynie
Journal:  Brain       Date:  2015-04-16       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.